Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

ClinicalTrials.gov ID: NCT00128492

Public ClinicalTrials.gov record NCT00128492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label, Follow-On Study of Multiple Courses of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients (AIR-CF3)

Study identification

NCT ID
NCT00128492
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
274 participants

Conditions and interventions

Interventions

  • AZLI 75 mg two times a day (BID)/ three times a day (TID) Drug

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Oct 31, 2008
Completion
Dec 31, 2008
Last update posted
May 18, 2011

2005 – 2009

United States locations

U.S. sites
56
U.S. states
30
U.S. cities
56
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Anchorage Alaska
Not listed Phoenix Arizona
Not listed Little Rock Arkansas
Not listed La Jolla California
Not listed Los Angeles California
Not listed Oakland California
Not listed Orange California
Not listed Denver Colorado
Not listed Hartford Connecticut
Not listed New Haven Connecticut
Not listed Jacksonville Florida
Not listed Orlando Florida
Not listed Atlanta Georgia
Not listed Augusta Georgia
Not listed Chicago Illinois
Not listed Glenview Illinois
Not listed Maywood Illinois
Not listed Park Ridge Illinois
Not listed Indianapolis Indiana
Not listed Wichita Kansas
Not listed Shreveport Louisiana
Not listed Boston Massachusetts
Not listed Ann Arbor Michigan
Not listed Detroit Michigan
Not listed Minneapolis Minnesota
Not listed Columbia Missouri
Not listed St Louis Missouri
Not listed Las Vegas Nevada
Not listed Livingston New Jersey
Not listed Morristown New Jersey
Not listed Albany New York
Not listed Brooklyn New York
Not listed Buffalo New York
Not listed New Hyde Park New York
Not listed New York New York
Not listed Syracuse New York
Not listed Valhalla New York
Not listed Chapel Hill North Carolina
Not listed Akron Ohio
Not listed Cincinnati Ohio
Not listed Columbus Ohio
Not listed Dayton Ohio
Not listed Oklahoma City Oklahoma
Not listed Hershey Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Pittsburgh Pennsylvania
Not listed Charleston South Carolina
Not listed Columbia South Carolina
Not listed Houston Texas
Not listed San Antonio Texas
Not listed Salt Lake City Utah
Not listed Portsmouth Virginia
Not listed Richmond Virginia
Not listed Seattle Washington
Not listed Morgantown West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00128492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00128492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →